文献
J-GLOBAL ID:201102247633941519
整理番号:11A1268595
転移性結腸直腸癌(mCRC)の患者(pts)におけるイリノテカン,S-1及びベバシズマブ併用(IRIS+BV)と修飾FOLFILIとBV(mmFOLFILI+BV)を比較したランダム化パイロット試験:T-CORE0702の結果
A randomized pilot study comparing safety and efficacy of irinotecan plus S-1 plus bevacizumab (IRIS+BV) and modified FOLFIRI plus BV (mFOLFIRI+BV) in patients (pts) with metastatic colorectal cancer (mCRC): The result of T-CORE0702
著者 (17件):
GAMOH Makio
(Osaki Citizen Hospital)
,
GAMOH Makio
(South Miyagi Medical Center)
,
KATO Shunsuke
(Tohoku Univ.)
,
ANDOH Hideaki
(Akita Univ. Graduate School of Medicine)
,
ANDOH Hideaki
(Nakadori General Hospital)
,
YAMAGUCHI Takuhiro
(Tohoku Univ.)
,
MAEDA Shunichi
(Hachinohe city hospital)
,
SASAKI Yuka
(Tohoku Univ.)
,
SUZUKI Takao
(Sendai Medical Center)
,
KATO Satoshi
(Iwate Prefectural Central Hospital)
,
OSADA Motonobu
(Ishinomaki Red Cross Hospital)
,
MIURA Koh
(Tohoku Univ. Graduate School of Medicine)
,
TAKAHATA Takenori
(Hirosaki Univ.)
,
SUTO Takeshi
(Yamagata Prefectural Central Hospital)
,
SHIIBA Ken-ichi
(Miyagi Cancer Center)
,
YOSHIOKA Takashi
(Yamagata Univ.)
,
ISHIOKA Chikashi
(Tohoku Univ.)
資料名:
日本臨床腫瘍学会学術集会プログラム・抄録集
(Abstracts. Annual Meeting of Japanese Society of Medical Oncology)
巻:
9th
ページ:
303
発行年:
2011年
JST資料番号:
L7804A
資料種別:
会議録 (C)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)